Heated belly treatment plus immunotherapy for advanced ovarian cancer
Part of Cancer, Immune system & allergy, Women’s health & pregnancy clinical trials.
This study tests a treatment that uses heated chemotherapy directly in the belly (called hyperthermic intraperitoneal treatment) combined with an immunotherapy drug to see if it can make the immune therapy work better for advanced ovarian cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have advanced ovarian cancer (stage IIIC or IVA) that is high-grade serous.
- You should be between 18 and 70 years old.
- You need to be in good enough health to have a life expectancy of at least 12 months.
- Your cancer must meet specific scores from a laparoscopic exam (an operation to look inside your belly).
- Your liver, kidney, and blood counts must be within certain limits.
- You should not have conditions like bowel obstruction, active infections, or autoimmune diseases.
- You must not have had immunotherapy, radiation to the pelvis/abdomen, or HIPEC (heated chemo into the belly) before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving heated chemotherapy directly into the belly during surgery for stomach cancer. It might help people with cancer that has spread to the lining of the belly but not to other organs.
This trial tests a new way of combining chemotherapy and surgery to treat advanced ovarian, fallopian tube, or primary peritoneal cancer. It aims to see if giving chemotherapy directly into the abdomen during surgery (HIPEC) helps people live longer.
This trial looks at whether a heated chemotherapy treatment given in the abdomen during a planned second surgery (HIPEC) can improve outcomes for certain advanced ovarian cancers. It is for people who have already had initial chemotherapy and partially responded, with enough health to safely undergo surgery.
This trial combines heated chemotherapy directly into the abdomen (HIPEC) with standard chemotherapy and an immunotherapy drug to treat advanced stomach cancer that has spread to the lining of the abdomen. The goal is to see if this combination can shrink tumors and help patients live longer.
This trial studies whether adding a special heated chemotherapy treatment during surgery (called HIPEC) improves outcomes for some people with ovarian, fallopian tube, or primary peritoneal cancer. It compares surgery alone versus surgery plus HIPEC after you’ve had chemotherapy first.
This trial tests a treatment called HIPEC (heated chemotherapy given directly into the abdomen during surgery) for stomach cancer that has spread to the lining of the belly. The goal is to see if this approach can help remove or shrink the cancer and improve outcomes.
Hear when a new HIPEC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.